Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Journal of Drug Targeting|July 7, 2007
Single-chain Fv immunoliposomes for the targeting of fibroblast activation protein-expressing tumor stromal cellsPatrick Baum, Dafne Müller, Ronny Rüger, et al.Journal of Pharmacological and Toxicological Methods|September 2, 2020
Characterization of iCell cardiomyocytes using single-cell RNA-sequencing methodsChristina Schmid, Christian T Wohnhaas, Tobias Hildebrandt, et al.Frontiers in Immunology|January 29, 2026
Interleukin-36 upregulates type-I interferon responses in systemic lupus erythematosus by promoting the accumulation of self-nucleic acidsEmma J Welsh, Daniel McCluskey, Patrick Baum, et al.Oligonucleotides|December 30, 2009
Off-target analysis of control siRNA molecules reveals important differences in the cytokine profile and inflammation response of human fibroblastsPatrick Baum, Katrin Fundel-Clemens, Sebastian Kreuz, et al.Nucleic Acids Research|March 3, 2010
Into the unknown: expression profiling without genome sequence information in CHO by next generation sequencingFabian Birzele, Jochen Schaub, Werner Rust, et al.Plos One|March 2, 2016
Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy PatientsDenis Delić, Claudia Eisele, Ramona Schmid, et al.Scientific Reports|July 25, 2019
DMSO cryopreservation is the method of choice to preserve cells for droplet-based single-cell RNA sequencingChristian T Wohnhaas, Germán G Leparc, Francesc Fernandez-Albert, et al.BMC Genomics|June 8, 2010
Comparison of normalization methods for Illumina BeadChip HumanHT-12 v3Ramona Schmid, Patrick Baum, Carina Ittrich, et al.The Journal of Allergy and Clinical Immunology|October 22, 2021
Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasisPatrick Baum, Sudha Visvanathan, Sandra Garcet, et al.Dermatology and Therapy|March 4, 2021
Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot StudyUlrich Mrowietz, A David Burden, Andreas Pinter, et al.Pageof 4